Titre : Toxidermies

Toxidermies : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Toxidermies : Questions médicales les plus fréquentes", "headline": "Toxidermies : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Toxidermies : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-27", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Toxidermies" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypersensibilité médicamenteuse", "url": "https://questionsmedicales.fr/mesh/D004342", "about": { "@type": "MedicalCondition", "name": "Hypersensibilité médicamenteuse", "code": { "@type": "MedicalCode", "code": "D004342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pustulose exanthématique aigüe généralisée", "alternateName": "Acute Generalized Exanthematous Pustulosis", "url": "https://questionsmedicales.fr/mesh/D056150", "about": { "@type": "MedicalCondition", "name": "Pustulose exanthématique aigüe généralisée", "code": { "@type": "MedicalCode", "code": "D056150", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.174" } } }, { "@type": "MedicalWebPage", "name": "Syndrome d'hypersensibilité médicamenteuse", "alternateName": "Drug Hypersensitivity Syndrome", "url": "https://questionsmedicales.fr/mesh/D063926", "about": { "@type": "MedicalCondition", "name": "Syndrome d'hypersensibilité médicamenteuse", "code": { "@type": "MedicalCode", "code": "D063926", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.262" } } }, { "@type": "MedicalWebPage", "name": "Érythème noueux", "alternateName": "Erythema Nodosum", "url": "https://questionsmedicales.fr/mesh/D004893", "about": { "@type": "MedicalCondition", "name": "Érythème noueux", "code": { "@type": "MedicalCode", "code": "D004893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.375" } } }, { "@type": "MedicalWebPage", "name": "Syndrome mains-pieds", "alternateName": "Hand-Foot Syndrome", "url": "https://questionsmedicales.fr/mesh/D060831", "about": { "@type": "MedicalCondition", "name": "Syndrome mains-pieds", "code": { "@type": "MedicalCode", "code": "D060831", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.587" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Nicolau", "alternateName": "Nicolau Syndrome", "url": "https://questionsmedicales.fr/mesh/D065148", "about": { "@type": "MedicalCondition", "name": "Syndrome de Nicolau", "code": { "@type": "MedicalCode", "code": "D065148", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.693" } } }, { "@type": "MedicalWebPage", "name": "Maladie sérique", "alternateName": "Serum Sickness", "url": "https://questionsmedicales.fr/mesh/D012713", "about": { "@type": "MedicalCondition", "name": "Maladie sérique", "code": { "@type": "MedicalCode", "code": "D012713", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.800" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Stevens-Johnson", "alternateName": "Stevens-Johnson Syndrome", "url": "https://questionsmedicales.fr/mesh/D013262", "about": { "@type": "MedicalCondition", "name": "Syndrome de Stevens-Johnson", "code": { "@type": "MedicalCode", "code": "D013262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C25.100.468.380.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Toxidermies", "alternateName": "Drug Eruptions", "code": { "@type": "MedicalCode", "code": "D003875", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yu Sawada", "url": "https://questionsmedicales.fr/author/Yu%20Sawada", "affiliation": { "@type": "Organization", "name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan." } }, { "@type": "Person", "name": "Natsuko Saito-Sasaki", "url": "https://questionsmedicales.fr/author/Natsuko%20Saito-Sasaki", "affiliation": { "@type": "Organization", "name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan." } }, { "@type": "Person", "name": "Teresa Correia", "url": "https://questionsmedicales.fr/author/Teresa%20Correia", "affiliation": { "@type": "Organization", "name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal." } }, { "@type": "Person", "name": "Paulo Filipe", "url": "https://questionsmedicales.fr/author/Paulo%20Filipe", "affiliation": { "@type": "Organization", "name": "Dermatology and Venereology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte EPE, Lisbon, Portugal." } }, { "@type": "Person", "name": "Etsuko Okada", "url": "https://questionsmedicales.fr/author/Etsuko%20Okada", "affiliation": { "@type": "Organization", "name": "Department of Dermatology University of Occupational and Environmental Health Kitakyushu Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } }, { "@type": "ScholarlyArticle", "name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.", "datePublished": "2024-09-24", "url": "https://questionsmedicales.fr/article/39317454", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rmdopen-2024-004600" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles dus à des produits chimiques", "item": "https://questionsmedicales.fr/mesh/D064419" }, { "@type": "ListItem", "position": 3, "name": "Effets secondaires indésirables des médicaments", "item": "https://questionsmedicales.fr/mesh/D064420" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité médicamenteuse", "item": "https://questionsmedicales.fr/mesh/D004342" }, { "@type": "ListItem", "position": 5, "name": "Toxidermies", "item": "https://questionsmedicales.fr/mesh/D003875" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Toxidermies - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Toxidermies", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Toxidermies", "description": "Comment diagnostiquer une toxidermie ?\nQuels tests sont utilisés pour confirmer une toxidermie ?\nQuels signes cliniques indiquent une toxidermie ?\nLes antécédents médicaux sont-ils importants ?\nPeut-on confondre une toxidermie avec d'autres affections ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Toxidermies", "description": "Quels sont les symptômes courants d'une toxidermie ?\nLes symptômes varient-ils selon le médicament ?\nUne toxidermie peut-elle provoquer des symptômes systémiques ?\nLes éruptions cutanées sont-elles toujours présentes ?\nLes démangeaisons sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Toxidermies", "description": "Comment prévenir les toxidermies ?\nLes tests allergiques sont-ils utiles ?\nFaut-il informer les médecins de ses allergies ?\nLes patients doivent-ils lire les notices des médicaments ?\nLes médicaments en vente libre sont-ils sûrs ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Toxidermies", "description": "Quel est le traitement principal d'une toxidermie ?\nDes antihistaminiques sont-ils recommandés ?\nLes corticostéroïdes sont-ils utilisés ?\nFaut-il consulter un dermatologue ?\nLes soins de la peau sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Toxidermies", "description": "Quelles complications peuvent survenir ?\nLes infections peuvent-elles être une complication ?\nUne hospitalisation est-elle parfois nécessaire ?\nLes complications peuvent-elles être évitées ?\nLes séquelles cutanées sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Toxidermies", "description": "Quels sont les facteurs de risque de toxidermie ?\nLes maladies chroniques influencent-elles le risque ?\nLes femmes sont-elles plus à risque ?\nL'utilisation de plusieurs médicaments augmente-t-elle le risque ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D003875?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une toxidermie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique médicamenteux du patient." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une toxidermie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés ou des biopsies peuvent être réalisés pour confirmer le diagnostic." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une toxidermie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons et parfois des symptômes systémiques peuvent apparaître." } }, { "@type": "Question", "name": "Les antécédents médicaux sont-ils importants ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents d'allergies médicamenteuses aident à établir le diagnostic." } }, { "@type": "Question", "name": "Peut-on confondre une toxidermie avec d'autres affections ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres dermatites ou infections cutanées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une toxidermie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des éruptions cutanées, démangeaisons, et parfois de la fièvre." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le médicament ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction du type de médicament impliqué." } }, { "@type": "Question", "name": "Une toxidermie peut-elle provoquer des symptômes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fièvre, des douleurs articulaires ou des troubles respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Les éruptions cutanées sont-elles toujours présentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certaines toxidermies peuvent ne pas présenter d'éruptions cutanées visibles." } }, { "@type": "Question", "name": "Les démangeaisons sont-elles fréquentes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les démangeaisons sont un symptôme courant dans de nombreuses toxidermies." } }, { "@type": "Question", "name": "Comment prévenir les toxidermies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les médicaments connus pour provoquer des réactions cutanées est essentiel." } }, { "@type": "Question", "name": "Les tests allergiques sont-ils utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests allergiques peuvent aider à identifier les médicaments à éviter." } }, { "@type": "Question", "name": "Faut-il informer les médecins de ses allergies ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toujours informer les professionnels de santé de ses allergies médicamenteuses." } }, { "@type": "Question", "name": "Les patients doivent-ils lire les notices des médicaments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, lire les notices peut aider à identifier les risques d'éruptions cutanées." } }, { "@type": "Question", "name": "Les médicaments en vente libre sont-ils sûrs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, certains médicaments en vente libre peuvent aussi provoquer des toxidermies." } }, { "@type": "Question", "name": "Quel est le traitement principal d'une toxidermie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement à arrêter le médicament responsable et à gérer les symptômes." } }, { "@type": "Question", "name": "Des antihistaminiques sont-ils recommandés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antihistaminiques peuvent aider à soulager les démangeaisons et l'inconfort." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des corticostéroïdes topiques ou systémiques peuvent être prescrits pour réduire l'inflammation." } }, { "@type": "Question", "name": "Faut-il consulter un dermatologue ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consultation dermatologique est souvent nécessaire pour un traitement approprié." } }, { "@type": "Question", "name": "Les soins de la peau sont-ils importants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins doux de la peau peuvent aider à apaiser les irritations cutanées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves comme le syndrome de Stevens-Johnson peuvent survenir." } }, { "@type": "Question", "name": "Les infections peuvent-elles être une complication ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections secondaires peuvent survenir en raison de lésions cutanées." } }, { "@type": "Question", "name": "Une hospitalisation est-elle parfois nécessaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hospitalisation peut être nécessaire pour des cas graves de toxidermie." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un traitement précoce et approprié." } }, { "@type": "Question", "name": "Les séquelles cutanées sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles cutanées comme des cicatrices peuvent survenir après une toxidermie." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de toxidermie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies, l'âge avancé et la polypharmacie augmentent le risque." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies chroniques peuvent augmenter la susceptibilité aux toxidermies." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent que les femmes peuvent être plus susceptibles aux toxidermies." } }, { "@type": "Question", "name": "L'utilisation de plusieurs médicaments augmente-t-elle le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la prise de plusieurs médicaments simultanément augmente le risque d'éruptions." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'allergies médicamenteuses peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...